Lees Pharmaceutical Holdings Price Prediction
| LPCUFDelisted Stock | USD 0.0001 0.00 0.00% |
Oversold Vs Overbought
57
Oversold | Overbought |
Using Lees Pharmaceutical hype-based prediction, you can estimate the value of Lees Pharmaceutical Holdings from the perspective of Lees Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Lees Pharmaceutical to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Lees because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Lees Pharmaceutical after-hype prediction price | USD 1.25E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Lees |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lees Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lees Pharmaceutical After-Hype Price Prediction Density Analysis
As far as predicting the price of Lees Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lees Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Lees Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Lees Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Lees Pharmaceutical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lees Pharmaceutical's historical news coverage. Lees Pharmaceutical's after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Lees Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Lees Pharmaceutical is out of control at this time. Analysis and calculation of next after-hype price of Lees Pharmaceutical is based on 3 months time horizon.
Lees Pharmaceutical Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Lees Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lees Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lees Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 2 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0001 | 0.0001 | 25.00 |
|
Lees Pharmaceutical Hype Timeline
Lees Pharmaceutical is now traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Lees is anticipated to increase in value after the next headline, with the price projected to jump to 1.25E-4 or above. The average volatility of media hype impact on the company the price is insignificant. The price rise on the next news is estimated to be 25.0%, whereas the daily expected return is now at 0.0%. The volatility of related hype on Lees Pharmaceutical is about 0.0%, with the expected price after the next announcement by competition of 0.00. Lees Pharmaceutical Holdings has accumulated 84.09 M in total debt with debt to equity ratio (D/E) of 0.11, which may suggest the company is not taking enough advantage from borrowing. Lees Pharmaceutical has a current ratio of 1.02, suggesting that it may not be capable to disburse its financial obligations in time and when they become due. Debt can assist Lees Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, Lees Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Lees Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Lees to invest in growth at high rates of return. When we think about Lees Pharmaceutical's use of debt, we should always consider it together with cash and equity.Assuming the 90 days horizon the next anticipated press release will be uncertain. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.Lees Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Lees Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Lees Pharmaceutical's future price movements. Getting to know how Lees Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lees Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ASLE | AerSale Corp | (0.11) | 9 per month | 2.49 | 0.08 | 6.59 | (5.14) | 15.01 | |
| EVOHD | EvoAir Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FNNNF | Finnair Oyj | 0.00 | 0 per month | 0.00 | (0.11) | 0.00 | 0.00 | 19.58 | |
| ALNT | Allient | 0.37 | 8 per month | 2.37 | 0.06 | 5.25 | (4.45) | 11.31 | |
| ARW | Arrow Electronics | (2.23) | 8 per month | 0.00 | (0.12) | 2.56 | (1.98) | 15.96 | |
| MFGCF | Mayfair Gold Corp | 0.00 | 0 per month | 1.99 | (0.01) | 3.40 | (4.76) | 15.39 |
Lees Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Lees price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lees using various technical indicators. When you analyze Lees charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Lees Pharmaceutical Predictive Indicators
The successful prediction of Lees Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lees Pharmaceutical Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lees Pharmaceutical based on analysis of Lees Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lees Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lees Pharmaceutical's related companies.
Story Coverage note for Lees Pharmaceutical
The number of cover stories for Lees Pharmaceutical depends on current market conditions and Lees Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lees Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lees Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Lees Pharmaceutical Short Properties
Lees Pharmaceutical's future price predictability will typically decrease when Lees Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Lees Pharmaceutical Holdings often depends not only on the future outlook of the potential Lees Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lees Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 588.8 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Lees Pink Sheet
If you are still planning to invest in Lees Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lees Pharmaceutical's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |